Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.5031
-0.0139 (-2.69%)
At close: Dec 30, 2025, 4:00 PM EST
0.5027
-0.0004 (-0.08%)
After-hours: Dec 30, 2025, 7:06 PM EST
Longeveron Market Cap
Longeveron has a market cap or net worth of $10.73 million as of December 30, 2025. Its market cap has decreased by -61.11% in one year.
Market Cap
10.73M
Enterprise Value
2.47M
1-Year Change
-61.11%
Ranking
Category
Stock Price
$0.50
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $10.73M, a decrease of -93.78%. That is a compound annual growth rate of -43.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 10.73M | -58.19% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | 172.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |